Hepatocellular cancer patients with higher expression of PSMD10 were found to be characterized by increased tumor size, vascular invasion as well as intrahepatic or distant metastasis and would suffer a poor OS or shorter DFS than low-expression patients [9]. The gene discussed is PSMD10; the disease is neoplasm.